Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune | Read
PUBLISHED ON: August 26, 2020 | Duration: 0 min, 20 sec
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
